1 |
Vinh-Hung V, Nguyen NP, Cserni G, et al (2009). Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol, 5, 1585-603.
DOI
ScienceOn
|
2 |
Vinh-Hung V, Verkooijen HM, Fioretta G, et al (2009). Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol, 27, 1062-8.
DOI
ScienceOn
|
3 |
Woodward WA, Vinh-Hung V, Ueno NT, et al (2006). Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol, 24, 2910-6.
DOI
ScienceOn
|
4 |
Ziaei JE, Pourzand A, Bayat A, Vaez J (2012). Patterns of metastasis and survival in breast cancer patients: a preliminary study in an Iranian population. Asian Pac J Cancer Prev, 13, 937-40.
과학기술학회마을
DOI
ScienceOn
|
5 |
Alanko A, Heinonen E, Scheinin T, et al (1985). Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients. Cancer, 56, 1696-700.
DOI
|
6 |
Barnholtz-Sloan JS, Sloan AE, Davis FG, et al (2004). Incidence proportions of brain metastases in patients diagnosed (1973e2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol, 22, 2865-72.
DOI
ScienceOn
|
7 |
Chia S, Norris B, Speers C, et al (2008). Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. J Clin Oncol, 26, 5697-704.
DOI
ScienceOn
|
8 |
Dayan A, Koca D, Akman T, et al (2012). The factors that have an impact on the development of brain metastasis in the patients with breast cancer. J Cancer Res Ther, 8, 542-8.
DOI
ScienceOn
|
9 |
Engel J, Eckel R, Aydemir U (2003). Determinants and prognoses of locoregional and distant progression in breast cancer. Int J Radiat Oncol Biol Phys, 55, 1186-95.
DOI
ScienceOn
|
10 |
Goldhirsc A, Wood WC, Coates AS, et al (2011). Strategies for subtypes-dealing with the diversity of breast cancer:highlights of the St. gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol, 22, 1736-47.
DOI
ScienceOn
|
11 |
Gong Y, Han EY, Guo M, Pusztai L, Sneige L (2011). Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy. Cancer, 117, 705-13.
DOI
ScienceOn
|
12 |
Greene FL, Page DL, Fleming ID, et al (2002). American joint committee on cancer. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag.
|
13 |
Hatoum HA, Jamali FR, El-Saghir NS, et al (2009). Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Ann Surg Oncol, 16, 3388-95.
DOI
|
14 |
Hoefnagel LD, van de Vijver MJ, van Slooten HJ, et al (2010). Receptor conversion in distant breast cancer metastases. Breast Cancer Res, 12, 75.
DOI
ScienceOn
|
15 |
Karlsson E, Lindstrom LS, Wilking U, Skoog L, Johansson U (2010). Discordance in hormone receptor status in breast cancer during tumor progression. J Clin Oncol, 28, 1009.
|
16 |
Kennecke H, Yerushalmi R, Woods R, et al (2010). Metastatic Behavior of Breast Cancer Subtypes. J Clin Oncol, 28, 3271-7.
DOI
ScienceOn
|
17 |
Li Y, Holmes E, Shah K, et al (2012). The prognostic value of lymph node cross-sectional cancer area in node-positive breast cancer: a comparison with N stage and lymph node ratio. Patholog Res Int, 2012, 161964.
|
18 |
Lin NU, Bellon JR, Winer EP (2004). CNS metastases in breast cancer. J Clin Oncol, 22, 3608-17.
DOI
ScienceOn
|